Hainan Poly Pharm (300630.SZ): Busulfex injection granted temporary approval by the US FDA.
PulicPharma (300630.SZ) announced that the company recently received a notification from the U.S. Food and Drug Administration (FDA)...
Hainan Poly Pharm (300630.SZ) announced that the company recently received temporary approval from the Food and Drug Administration (FDA) of the United States for the injection of Brivudine. The indication for this drug is the treatment of partial onset seizures in patients aged 1 month and older.
Related Articles
HK Stock Market Move | SINOMAB BIO-B(03681) rose more than 7% in the afternoon. The first cohort of healthy subjects in China completed dosing for the subcutaneous injection bridging study of SM17.
Bank of America Securities: AIA's (01299) new business value is expected to grow by 15% in the third quarter, maintaining a "buy" rating.
HK Stock Market Move | ZOOMLION (01157) rose more than 5% in September, with the excavator industry's domestic and global market sentiment on the rise. Institutions point to it as an undervalued target for Siasun Robot & Automation.
HK Stock Market Move | SINOMAB BIO-B(03681) rose more than 7% in the afternoon. The first cohort of healthy subjects in China completed dosing for the subcutaneous injection bridging study of SM17.
Bank of America Securities: AIA's (01299) new business value is expected to grow by 15% in the third quarter, maintaining a "buy" rating.
HK Stock Market Move | ZOOMLION (01157) rose more than 5% in September, with the excavator industry's domestic and global market sentiment on the rise. Institutions point to it as an undervalued target for Siasun Robot & Automation.
RECOMMEND
